Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.032540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Lukas Lanser und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II Medical University of Innsbruck Innsbruck Austria. Hauptthemen laut MEDLINE: Heart Failure, Iron, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Iron deficiency (ID) is a frequent comorbidity in patients with acute (AHF) and chronic heart failure (CHF) associated with morbidity and death. We aimed to better characterize iron homeostasis in patients with heart failure applying different biomarkers and to evaluate the accuracy of current ID definition by the European Society of Cardiology/American College of Cardiology/American Heart Association to indicate tissue iron availability and demand. Methods and Results We performed a retrospective cohort study investigating 277 patients with AHF and 476 patients with CHF between February 2021 and May 2022. Patients with AHF had more advanced ID than patients with CHF, reflected by increased soluble transferrin receptor and soluble transferrin receptor–ferritin index, and lower ferritin, serum iron, transferrin saturation, hepcidin, and reticulocyte hemoglobin. Decreased iron availability or increased tissue iron demand, reflected by increased soluble transferrin receptor–ferritin index and decreased reticulocyte hemoglobin, was found in 84.1% (AHF) and 28.0% (CHF) with absolute ID and in 50.0% (AHF) and 10.5% (CHF) with combined ID according to the current European Society of Cardiology/American College of Cardiology/American Heart Association–based ID definition. Low hepcidin expression as an indicator of systemic ID was found in 91.1% (AHF) and 80.4% (CHF) of patients with absolute ID and in 32.3% (AHF) and 18.8% (CHF) of patients with combined ID. ID definitions with higher specificity reduce the need for iron supplementation by 25.5% in patients with AHF and by 65.6% in patients with CHF.
Conclusions
Our results suggest that the current European Society of Cardiology/American College of Cardiology/American Heart Association–based ID definition might overestimate true ID, particularly in CHF. More stringent thresholds for ID could more accurately identify patients with heart failure with reduced tissue iron availability who benefit from intravenous iron supplementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine II Medical University of Innsbruck Innsbruck Austria.
- Department of Internal Medicine III Medical University of Innsbruck Innsbruck Austria.
- Institute of Medical Statistics and Informatics Medical University of Innsbruck Innsbruck Austria.
ORCID-Profile: Lukas Lanser, Moritz Messner, Maria Ungericht, Marc-Michael Zaruba, Jakob Hirsch, Bernhard Koller, Hanno Ulmer, Guenter Weiss
Zitieren
APA
Lanser, L., Poelzl, G., Messner, M., Ungericht, M., Zaruba, M. M., Hirsch, J., Hechenberger, S., Obersteiner, S., Koller, B., Ulmer, H., & Weiss, G. (2024). Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032540
Vancouver
Lanser L, Poelzl G, Messner M, Ungericht M, Zaruba MM, Hirsch J, et al. Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032540
BibTeX
@article{Lanser2024,
author = {Lanser, Lukas and Poelzl, Gerhard and Messner, Moritz and Ungericht, Maria and Zaruba, Marc-Michael and Hirsch, Jakob and Hechenberger, Stefan and Obersteiner, Stefan and Koller, Bernhard and Ulmer, Hanno and Weiss, Guenter},
title = {Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.032540}
}
EUVIMED